(Frontal 21 ZDF)
ZDF has reported on CRP apheresis treatment for COVID-19 patients.
At the Klinikum Havelhöhe, the therapy is now used for many severely ill Corona patients - with promising results. Nevertheless, all funding applications for a large clinical trial were unsuccessfully rejected. The trial is needed to make the therapy available to COVID-19 patients throughout Germany.
In this context, ZDF also reports on the fundamental problem that almost all funding goes to the development and production of vaccines, but hardly any research into therapies, medical devices or drugs is supported.
The detailed report was broadcast on Frontal 21 and can be viewed in German here.